Cat.#: ACPP-1343
| Despition | GIRK1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1400 | ACTH (AC1400) | 2 mg | inquiry |
| ACPP-1154 | Recombinant Human FGF19 Protein (6×His Tag) (AC1154) | 50 µg | inquiry |
| ACPP-1217 | P2Y2 Blocking Peptide (AC1217) | 250 µg | inquiry |
| ACPP-1350 | Presenilin 2 Blocking Peptide (AC1350) | 250 µg | inquiry |
| ACPP-1587 | Human TMED10 Protein (AC1587) | 2 µg | inquiry |
| ACPP-1484 | Human CPE Protein (AC1484) | 5 µg | inquiry |
| ACPP-1421 | Human il-6 Protein, HEK (AC1421) | 2 µg | inquiry |
| ACPP-1504 | Human CPLX1 Protein (AC1504) | 10 µg | inquiry |
| ACPP-1829 | Human SNAPIN Protein (AC1829) | 10 µg | inquiry |
| ACPP-1346 | GFAP Blocking Peptide (AC1346) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.